$HRTX HERON THERAPEUTICS, INC. /DE/ Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in HERON THERAPEUTICS, INC. /DE/.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in HERON THERAPEUTICS, INC. /DE/. Insider overview, share value development, latest insider transactions and email notifications about new events in HERON THERAPEUTICS, INC. /DE/ for free.

CIK Number: 0000818033
IRS Number: 942875566
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: HRTX
Company Address: 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO 92121
Phone number: 6503662626
Former name: ADVANCED POLYMER SYSTEMS INC /DE/, date of change: 1992-07-03
Former name: ADVANCED POLYMER SYSTEMS INC /DE/, date of change: 1992-07-03
Former name: AP PHARMA INC /DE/, date of change: 2001-05-11

Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer or pain. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its primary products are SUSTOL, HTX-019 and HTX-011. The company has additional clinical and preclinical-stage programs in the area of pain management, all of which utilize its bio erodible, injectable and implantable delivery systems. Heron Therapeutics was founded in February 1983 and is headquartered in Redwood City, CA.

Prev close: $13.35
Average Daily Volume: 994,703
Days Low: $12.95
Year Low: $12.21
Year High: $25.46

HERON THERAPEUTICS, INC. /DE/ Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 24 2017HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...Option ExerciseM9.0516,292147,4430
Apr 24 2017HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...Option ExerciseM8.805,25046,2000
Apr 24 2017HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...SellS15.3321,542330,263021.5 K to 0 (-100.00 %)
Apr 24 2017HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...BuyM9.0516,292147,44321,5425.3 K to 21.5 K (+310.32 %)
Apr 24 2017HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...BuyM8.805,25046,2005,2500 to 5.3 K
Apr 24 2017HRTXHERON THERAPEUTICS ...HOFFMAN ROBERTCFO & SVP, FinanceOption ExerciseA15.30130,0001,989,000130,000
Apr 07 2017HRTXHERON THERAPEUTICS ...Christian WaageDirectorOption ExerciseA13.501,12515,1881,125
Jan 23 2017HRTXHERON THERAPEUTICS ...POYHONEN JOHNDirectorBuyP12.2010,000122,00010,0000 to 10 K
Jan 23 2017HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorBuyP12.202,459,01629,999,9958,332,9075.9 M to 8.3 M (+41.86 %)
Dec 23 2016HRTXHERON THERAPEUTICS ...Christian WaageDirectorOption ExerciseA13.0015,500201,50015,500
Dec 23 2016HRTXHERON THERAPEUTICS ...POYHONEN JOHNDirectorOption ExerciseA13.0019,500253,50019,500
Dec 23 2016HRTXHERON THERAPEUTICS ...Johnson Craig ADirectorOption ExerciseA13.0021,000273,00021,000
Dec 23 2016HRTXHERON THERAPEUTICS ...Rosen RobertPresidentOption ExerciseA13.00310,0004,030,000310,000
Dec 23 2016HRTXHERON THERAPEUTICS ...Quart Barry DChief Executive Off ...Option ExerciseA13.00310,0004,030,000310,000
Dec 23 2016HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorOption ExerciseA13.0017,000221,00017,000

View all HERON THERAPEUTICS, INC. /DE/ insider transactions.